|
|||||||||||||||||||||||||||||||||||||||||||
|
|
Key: Meeting
Showing releases 101-125 out of 943. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>
Public Release: 1-May-2013
New federal investment could save millions of lives Thanks to new federal funding, low-cost, easily accessible technology invented by a Simon Fraser University engineering professor and his graduate students is closer to helping to save millions of infant lives. The lab-on-a-chip, designed by Ash Parameswaran and his students, is among 102 global research projects receiving $100,000 each through the federal government's Stars in Global Health program. Contact: Carol Thorbes Public Release: 1-May-2013
Rice U. professors share Lemelson-MIT award, donate prize money Rice University bioengineering professors Rebecca Richards-Kortum and Maria Oden, the winners of the 2013 $100,000 Lemelson-MIT Award for Global Innovation, are dedicating their prize money toward the construction of a new neonatal nursery at the African hospital that has helped implement Rice's low-cost, student-designed health care technologies since 2007. The nursery will improve patient care at Queen Elizabeth Central Hospital in Blantyre, Malawi, and support technology innovation through Rice's Day One project. Contact: Jade Boyd Public Release: 30-Apr-2013
Economics influence fertility rates more than other factors Based on a recent study by a University of Missouri anthropologist, economic changes have the greatest impact on reducing family size, and thus slowing population growth, compared to other factors. Understanding the causes of declining birth rates may lead to improved policies designed to influence fertility and result in reduced competition for food, water, land and wealth. Contact: Tim Wall Public Release: 29-Apr-2013
Warning system predicts outbreaks of dengue fever With the help of a warning system which measures the risk of dengue incidence using precipitation and air temperature, it is possible to forecast the outbreak of dengue fever up to 16 weeks in advance. This is what Yien Ling Hii concludes in the dissertation she is defending at Umeå University in Sweden on 3 May. Contact: Yien Ling Hii Public Release: 29-Apr-2013
Inventive: 102 bold new global health ideas win Grand Challenges Canada funding 59 innovators in 13 low and middle income countries and 43 in Canada will share $10.9 million in Canadian seed funding to pursue bold, creative ideas for tackling health problems in resource-poor parts of the world. The grants will advance 102 out-of-the-box innovations in remote diagnostics and monitoring, health protection, drug and vaccine development and accessibility, and other key health areas. Contact: Terry Collins Public Release: 26-Apr-2013
Developments in TACE and SIRT treatment in patients Data from a number of clinical trials presented today at the International Liver Congress™ 2013 shed new light on the use of TACE and SIRT in the treatment of hepatocellular carcinoma. Contact: Dimple Natali Public Release: 26-Apr-2013
New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells. Contact: Joseph Carey Public Release: 25-Apr-2013
A*STAR, Veredus create market's first lab-on-chip to detect multiple tropical infectious diseases The Agency for Science, Technology and Research and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTropTM, the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample. Contact: Dr. Sarah Chang Public Release: 25-Apr-2013
New studies prove lethal link between alcohol, weight Research announced today at the International Liver CongressTM 2013 has revealed the deadly impact that alcohol and body weight have on liver disease. Contact: Dimple Natali Public Release: 24-Apr-2013
Direct-acting antivirals now ready for prime time New data from a number of clinical trials presented for the first time at the International Liver Congress™ 2013 demonstrate encouraging results in the use of new direct-acting antiviral agents for the treatment of hepatitis C. Contact: Dimple Natali Public Release: 24-Apr-2013
NASH diagnosis set to improve with non-invasive tool A Chinese study presented at the International Liver CongressTM 2013 has demonstrated the accuracy of a non-invasive test for non-alcoholic steatohepatitis diagnosis. Contact: Dimple Natali Public Release: 23-Apr-2013
AfriCoLeish receives funding boost from European Union Research and development project, AfriCoLeish, is supported by the European Union Seventh Framework Programme through a grant of €3 million. The project will run for three years and aims to test new treatments for kala-azar (visceral leishmaniasis, or VL) and co-infection of the disease with HIV in Ethiopia and Sudan. Contact: Violaine Dällenbach Public Release: 17-Apr-2013
Anti-sickling therapies should be focus for sickle cell science Pain is an undeniable focal point for patients with sickle cell disease but it's not the best focus for drug development, says one of the dying breed of physicians specializing in the condition. Contact: Toni Baker Public Release: 17-Apr-2013
HIV-infected moms who breastfeed exclusively have lower levels of virus in breast milk HIV-infected women in sub-Saharan Africa who fed their babies exclusively with breast milk for more than the first four months of life had the lowest risk of transmitting the virus to their babies through breast milk. Women who stopped breast feeding earlier than four months had the highest concentrations of HIV in their breast milk, and those who continued to breastfeed, but not exclusively, had concentration levels in-between the two practices. Contact: stephanie berger Public Release: 16-Apr-2013
TGen-led study discovers dramatic changes in bacteria following male circumcision Male circumcision reduces the abundance of bacteria living on the penis and might help explain why circumcision offers men some protection against HIV, according to a study led by the Translational Genomics Research Institute. Contact: Steve Yozwiak Public Release: 16-Apr-2013
Haiti cholera mutations could lead to more severe disease The cholera strain that transferred to Haiti in 2010 has multiple toxin gene mutations that may account for the severity of disease and is evolving to be more like an 1800s version of cholera. Contact: Marla Paul Public Release: 15-Apr-2013
La Jolla Institute's surprising finding could alter the face of dengue vaccine development As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design. The finding runs counter to current scientific understanding of the key cells that need to be induced to develop a successful dengue vaccine. Contact: Bonnie Ward Public Release: 11-Apr-2013
Discovery points to new approach to fight dengue virus Researchers have discovered that rising temperature induces key changes in the dengue virus when it enters its human host, and the findings represent a new approach for designing vaccines against the aggressive mosquito-borne pathogen. Contact: Emil Venere Public Release: 11-Apr-2013
Polio eradication is achievable by 2018 and urgent, declare 400+ global scientists Hundreds of scientists and technical experts from 80 countries historically launched the Scientific Declaration on Polio Eradication on 11 Apr. 2013. The world has never been closer to a world free from polio. At this unique moment, scientists have come together to stress the achievability of polio eradication and endorse the Eradication and Endgame Strategic Plan, a new strategy by the Global Polio Eradication Initiative to reach and sustain eradication. Contact: Dan Pawson Public Release: 11-Apr-2013
Leading organizations back Global Action Plan More than 100 nongovernmental organizations and civil society organizations, joined by dozens of leading experts, expressed their support today for the World Health Organization and UNICEF's first-ever global plan to simultaneously tackle pneumonia and diarrhoea -- diseases that take the lives of almost two million children each year -- and urged governments and their partners to make the plan a reality. Contact: Guillermo Meneses Public Release: 11-Apr-2013
Cell-destroyer that fights and promotes TB reveals what's behind its split identity TB can be a disease not only of failed immunity but also of excessive immune response. Tumor necrosis factor -- normally an infection-fighting substance produced by the body -- can actually heighten susceptibility to tuberculosis if its levels are too high. Contact: Leila Gray Public Release: 11-Apr-2013
Launch of semi-synthetic artemisinin a milestone for malaria, synthetic biology The best therapy today for malaria is a drug combination that includes a derivative of artemisinin, now solely available from plants grown in Asia and Africa. On Apr. 11, Sanofi will launch the first semi-synthetic version of artemisinin, derived from yeast developed by biotech company Amyris from discoveries in the laboratory of Jay Keasling at UC Berkeley. Contact: Robert Sanders Public Release: 10-Apr-2013
Training gives kids of AIDS patients a leg up A simple in-home training program for caregivers can give children of AIDS patients a better shot at prosperity by improving their early-childhood development, according to a study led by a Michigan State University researcher. Contact: Andy McGlashen Public Release: 10-Apr-2013
In an economic crash, public health improves The economic crash in Cuba following the fall of the Soviet Union has provided researchers with a unique natural experiment on obesity, diabetes and heart disease, according to a study in the British Medical Journal. Contact: Jim Ritter Public Release: 10-Apr-2013
Researchers develop tool to assist areas of infectious disease outbreaks Researchers have developed a simple new tool to help governments worldwide decide whether to screen airplane passengers leaving or arriving from areas of infectious disease outbreaks. Contact: Leslie Shepherd
Showing releases 101-125 out of 943. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||